Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy

Archive ouverte

Bourgier, Céline | Lacombe, Jérôme | Solassol, Jérôme | Mangé, Alain | Pèlegrin, André | Ozsahin, Mahmut | Azria, David

Edité par CCSD ; Elsevier -

International audience. Radiation therapy undeniably enhances local control and thus improves overall survival in cancer patients. However, some long-term cancer survivors (less than 10%) develop severe late radio-induced toxicities altering their quality of life. Therefore, there is a need to identify patients who are sensitive to those toxicities and who could benefit from adapted care. In this review, we address all available techniques aiming to detect patients' hyper-radiosensitivity and present the scientific rationales these techniques are based on.

Consulter en ligne

Suggestions

Du même auteur

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Archive ouverte | Lacombe, Jérôme | CCSD

International audience. Background: Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been...

Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes

Archive ouverte | Lacombe, Jérôme | CCSD

International audience

A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women

Archive ouverte | Lacombe, Jérôme | CCSD

International audience. BACKGROUND: The sensitivity of mammography for the detection of small lesions, including node-negative early-stage (T1N0) primary breast cancer (PBC) and ductal carcinoma in situ (DCIS), is s...

Chargement des enrichissements...